Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 28.45% is in line with its 5-year average of 26.00%, around the middle of its 5-year range (19.63%–35.33%).
1.05% above its 12-month average of 28.15%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
28.45%
NET PROFIT MARGIN AVG TTM
28.15%
NET PROFIT MARGIN AVG 3Y
28.58%
NET PROFIT MARGIN AVG 5Y
26.00%
NET PROFIT MARGIN AVG 10Y
28.38%
NET PROFIT MARGIN AVG 15Y
27.59%
NET PROFIT MARGIN AVG 20Y
26.77%
CURRENT VS TTM AVG
+1.05%
CURRENT VS 3Y AVG
-0.45%
CURRENT VS 5Y AVG
+9.42%
CURRENT VS 10Y AVG
+0.26%
CURRENT VS 15Y AVG
+3.13%
CURRENT VS 20Y AVG
+6.28%
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+216.82%
vs the sector median at left
Intuitive Surgical, Inc.
Market Cap
$124.79B
Net Profit Margin
28.45%
TTM Avg
28.15%
3Y Avg
28.58%
5Y Avg
26.00%
Market Cap
$121.70B
Net Profit Margin
1.18%
TTM Avg
0.84%
3Y Avg
1.34%
5Y Avg
1.79%
Market Cap
$131.57B
Net Profit Margin
18.87%
TTM Avg
-1.95%
3Y Avg
6.91%
5Y Avg
3.60%
Market Cap
$117.62B
Net Profit Margin
13.93%
TTM Avg
13.55%
3Y Avg
12.62%
5Y Avg
13.06%
Market Cap
$132.26B
Net Profit Margin
34.89%
TTM Avg
13.94%
3Y Avg
25.44%
5Y Avg
29.40%
Market Cap
$105.57B
Net Profit Margin
14.43%
TTM Avg
13.09%
3Y Avg
13.60%
5Y Avg
12.87%
Market Cap
$144.11B
Net Profit Margin
15.95%
TTM Avg
15.52%
3Y Avg
19.51%
5Y Avg
19.37%
Market Cap
$104.40B
Net Profit Margin
1.12%
TTM Avg
1.05%
3Y Avg
1.09%
5Y Avg
0.48%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $124.79B | 28.45% | 28.15% | 28.58% | 26.00% |
| CVS Health Corp. (CVS)vs › | $121.70B | 1.18% | 0.84% | 1.34% | 1.79% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.57B | 18.87% | -1.95% | 6.91% | 3.60% |
| Medtronic plc (MDT)vs › | $117.62B | 13.93% | 13.55% | 12.62% | 13.06% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.26B | 34.89% | 13.94% | 25.44% | 29.40% |
| Stryker Corporation (SYK)vs › | $105.57B | 14.43% | 13.09% | 13.60% | 12.87% |
| Danaher Corporation (DHR)vs › | $144.11B | 15.95% | 15.52% | 19.51% | 19.37% |
| McKesson Corporation (MCK)vs › | $104.40B | 1.12% | 1.05% | 1.09% | 0.48% |
| Sanofi (SNY)vs › | $102.89B | 8.10% | 14.63% | 15.72% | 18.61% |
| GSK plc (GSK)vs › | $97.43B | 14.52% | 12.86% | 23.24% | 22.39% |
Operating Margin
31.3%
Net Profit Margin
28.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 28.29% |
| 2026-03-31 | 29.65% |
| 2025-12-31 | 27.73% |
| 2025-09-30 | 28.12% |
| 2025-06-30 | 26.98% |
| 2025-03-31 | 30.99% |
| 2024-12-31 | 28.41% |
| 2024-09-30 | 27.73% |
| 2024-06-30 | 26.22% |
| 2024-03-31 | 28.82% |
| 2023-12-31 | 31.44% |
| 2023-09-30 | 23.84% |
| 2023-06-30 | 23.96% |
| 2023-03-31 | 20.95% |
| 2022-12-31 | 19.63% |
| 2022-09-30 | 20.80% |
| 2022-06-30 | 20.22% |
| 2022-03-31 | 24.57% |
| 2021-12-31 | 24.54% |
| 2021-09-30 | 27.11% |
| 2021-06-30 | 35.33% |
| 2021-03-31 | 32.99% |
| 2020-12-31 | 27.48% |
| 2020-09-30 | 29.13% |
| 2020-06-30 | 7.98% |
| 2020-03-31 | 28.51% |
| 2019-12-31 | 28.00% |
| 2019-09-30 | 35.17% |
| 2019-06-30 | 28.97% |
| 2019-03-31 | 31.48% |
| 2018-12-31 | 27.95% |
| 2018-09-30 | 31.76% |
| 2018-06-30 | 28.08% |
| 2018-03-31 | 33.94% |
| 2017-12-31 | -4.35% |
| 2017-09-30 | 36.91% |
| 2017-06-30 | 29.29% |
| 2017-03-31 | 26.67% |
| 2016-12-31 | 26.95% |
| 2016-09-30 | 30.90% |
| 2016-06-30 | 27.53% |
| 2016-03-31 | 22.94% |
| 2015-12-31 | 28.09% |
| 2015-09-30 | 28.37% |
| 2015-06-30 | 22.95% |
| 2015-03-31 | 18.23% |
| 2014-12-31 | 24.28% |
| 2014-09-30 | 22.49% |
| 2014-06-30 | 20.30% |
| 2014-03-31 | 9.53% |
| 2013-12-31 | 28.84% |
| 2013-09-30 | 31.42% |
| 2013-06-30 | 27.50% |
| 2013-03-31 | 30.90% |
| 2012-12-31 | 28.71% |
| 2012-09-30 | 34.08% |
| 2012-06-30 | 28.87% |
| 2012-03-31 | 28.98% |
| 2011-12-31 | 30.43% |
| 2011-09-30 | 27.40% |
| 2011-06-30 | 27.58% |
| 2011-03-31 | 26.82% |
| 2010-12-31 | 31.13% |
| 2010-09-30 | 25.15% |
| 2010-06-30 | 25.29% |
| 2010-03-31 | 25.96% |
| 2009-12-31 | 24.01% |
| 2009-09-30 | 23.03% |
| 2009-06-30 | 23.94% |
| 2009-03-31 | 14.94% |
| 2008-12-31 | 21.92% |
| 2008-09-30 | 24.41% |
| 2008-06-30 | 23.35% |
| 2008-03-31 | 23.80% |
| 2007-12-31 | 25.95% |
| 2007-09-30 | 26.08% |
| 2007-06-30 | 21.86% |
| 2007-03-31 | 20.84% |
| 2006-12-31 | 21.00% |
| 2006-09-30 | 18.01% |
| 2006-06-30 | 19.17% |
| 2006-03-31 | 18.71% |
| 2005-12-31 | 68.70% |
| 2005-09-30 | 34.04% |
| 2005-06-30 | 28.02% |
| 2005-03-31 | 21.88% |
| 2004-12-31 | 25.85% |
| 2004-09-30 | 17.22% |
| 2004-06-30 | 15.55% |
| 2004-03-31 | 3.15% |
| 2003-12-31 | -17.59% |
| 2003-09-30 | -14.33% |
| 2003-06-30 | 4.09% |
| 2003-03-31 | -11.92% |
| 2002-12-31 | -12.30% |
| 2002-09-30 | -37.84% |
